SCHEMBL1597972

SCHEMBL1597972

Cc1cc(C(c2ccc(C(c3cc(C)c(O)c(C(C)(C)C)c3)c3cc(C)c(O)c(C(C)(C)C)c3)cc2)c2cc(C)c(O)c(C(C)(C)C)c2)cc(C(C)(C)C)c1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.55
CYP2C9 P11712 4/20 0.55
CYP2C19 P33261 4/20 0.55
GABRA1 P14867 1/20 0.46
GABRB2 P47870 1/20 0.46
CA2 P00918 4/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
ALDH1A1 P00352 3/20 0.45
POLB P06746 1/20 0.45
TYR P14679 1/20 0.45
CA1 P00915 2/20 0.42
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
CYP2D6 P10635 2/20 0.38
MEN1 O00255 1/20 0.38
GALR3 O60755 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HSPA5 P11021 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8772429 0.91 CYP1A2 (0.50) CYP1A2CYP2C9CYP2C19GABRA1GABRB2
SCHEMBL4061629 0.84 CA2 (0.46) CYP1A2CYP2C9CYP2C19GABRA1GABRB2
SCHEMBL1597804 0.82 CYP2C9 (0.61) CYP1A2CYP2C9CYP2C19GABRA1GABRB2
SCHEMBL30343456 0.82 CYP2C9 (0.61) CYP1A2CYP2C9CYP2C19GABRA1GABRB2
SCHEMBL1595123 0.82 CA1 (0.48) CYP1A2CYP2C9CA2ALDH1A1CA1
SCHEMBL8772288 0.82 CA2 (0.61) CYP1A2CYP2C9CYP2C19CA2SMN1; SMN2
SCHEMBL4450533 0.81 CYP2C9 (0.59) CYP1A2CYP2C9CYP2C19GABRA1GABRB2
SCHEMBL1151101 0.81 CYP2C9 (0.59) CYP1A2CYP2C9CYP2C19GABRA1GABRB2
SCHEMBL5446120 0.81 CYP1A2 (0.59) CYP1A2CYP2C9CYP2C19GABRA1GABRB2
SCHEMBL30467047 0.81 CYP2C9 (0.59) CYP1A2CYP2C9CYP2C19GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1780224-B1 MULTIBRANCHED POLYMERS AND PROCESS FOR PRODUCTION THEREOF NIPPON SODA CO (JP) 2015-02-18 EP disclosed
US-8710165-B2 Multibranched polymer and method for producing the same NIPPON SODA CO., LTD. (JP) 2014-04-29 US disclosed
US-20110152388-A1 Multibranched polymer and method for producing the same NIPPON SODA CO., LTD. (JP) 2011-06-23 US disclosed
US-7919570-B2 narrowly dispersed; controlled molecular weight; ionic conductivity, shape stability; battery adhesive or binder; 1,1,2,2-tetrakis(4-hydroxyphenyl)ethane or pentaerythritol reacted with bromoisobutyroyl bromide for core; living radical polymerization of acrylate or a styrene at halogen atoms as the arms NIPPON SODA CO., LTD. (JP) 2011-04-05 US disclosed
US-7601784-B2 1,1,2,2-tetrakis(4-hydroxyphenyl)ethane is used to molecular alignment, chemical stabilization, heat resist, flexiable and modification of the polyether having hydrogen bond sites; for waste water treatments, energy transducers, conductors NIPPON SODA CO., LTD. (JP) 2009-10-13 US disclosed
US-20080214685-A1 Multibrached Polymer and Method for Producing the Same NIPPON SODA CO., LTD. (JP) 2008-09-04 US disclosed
EP-1792947-A1 Molecular compound comprising polymer having hydrogen bond as component compound NIPPON SODA CO., LTD. (JP) 2007-06-06 EP disclosed
EP-1780224-A1 MULTIBRANCHED POLYMERS AND PROCESS FOR PRODUCTION THEREOF NIPPON SODA CO., LTD. (JP) 2007-05-02 EP disclosed
US-20020193528-A1 Molecular compound comprising polymer having hydrogen bond as component compound NIPPON SODA CO., LTD. (JP) 2002-12-19 US disclosed
EP-1241230-A1 MOLECULAR COMPOUND COMPRISING POLYMER HAVING HYDROGEN BOND AS COMPONENT COMPOUND NIPPON SODA CO., LTD. (JP) 2002-09-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193528-A1 Molecular compound comprising polymer having hydrogen bond as component compound PIEZO1, PARN, PARG CYP1A2 3704/4885CYP2C9 4374/4885CYP2C19 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.